Home/Filings/4/0001104659-11-065233
4//SEC Filing

Lundquist David J. 4

Accession 0001104659-11-065233

CIK 0001126234other

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 6:54 PM ET

Size

26.2 KB

Accession

0001104659-11-065233

Insider Transaction Report

Form 4
Period: 2011-11-16
Transactions
  • Conversion

    Series C Preferred Stock

    2011-11-1620,0000 total(indirect: By Trust)
    Common Stock (20,000 underlying)
  • Conversion

    Common Stock

    2011-11-16+13,26724,642 total(indirect: By Trust)
  • Conversion

    Common Stock

    2011-11-16+10,85645,021 total(indirect: By Trust)
  • Conversion

    Series AA Preferred Stock

    2011-11-1627,7800 total(indirect: By Trust)
    Common Stock (27,780 underlying)
  • Purchase

    Common Stock

    2011-11-16$7.00/sh+15,000$105,00087,630 total(indirect: By Trust)
  • Conversion

    Series B Preferred Stock

    2011-11-1619,9990 total(indirect: By Trust)
    Common Stock (19,999 underlying)
  • Conversion

    Series E Preferred Stock

    2011-11-165,2570 total(indirect: By Trust)
    Common Stock (5,257 underlying)
  • Conversion

    Common Stock

    2011-11-16+9,52334,165 total(indirect: By Trust)
  • Conversion

    Common Stock

    2011-11-16+27,60972,630 total(indirect: By Trust)
  • Gift

    Common Stock

    2011-11-1887,6300 total(indirect: By Trust)
  • Gift

    Common Stock

    2011-11-18+43,81543,815 total(indirect: By Trust)
  • Gift

    Common Stock

    2011-11-18+43,81543,815 total(indirect: By Trust)
Footnotes (5)
  • [F1]Every one share of Series AA Preferred Stock automatically converted into approximately 0.476 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date. Includes 39 shares acquired by dividend issued upon conversion of Series AA Preferred Stock.
  • [F2]Every one share of Series B Preferred Stock automatically converted into approximately 0.476 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date.
  • [F3]Every one share of Series C Preferred Stock automatically converted into approximately 0.542 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date.
  • [F4]Every one share of Series E Preferred Stock automatically converted into approximately 5.252 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date.
  • [F5]The shares were purchased in the Issuer's initial public offering.

Documents

1 file

Issuer

NEWLINK GENETICS CORP

CIK 0001126234

Entity typeother

Related Parties

1
  • filerCIK 0001512133

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 6:54 PM ET
Size
26.2 KB